Evidence map›Paper›PMID 40191667›Full record

ArticleJournal of surgical case reports2025

Role of mechanical hysteroscopic tissue removal system in post-molar gestational trophoblastic neoplasia management: case report and literature review.

Sophie Schoenen, Katty Delbecque, Frédéric Kridelka, Florence Hanocq, Frédéric Goffin, Patricia Nervo

Abstract readCase Reports
In one paragraph

Article in Journal of surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sophie SchoenenDépartement de Gynécologie-Obstétrique, Hôpital Universitaire de Liège, Université de Liège (ULiège), Avenue de L'Hôpital 1, 4000 Liège, Belgique.ORCID https://orcid.org/0000-0003-2064-9897
Katty DelbecqueDépartement d'Anatomie Pathologique, Hôpital Universitaire de Liège, Université de Liège (ULiège), Avenue de L'Hôpital 1, 4000 Liège, Belgique.
Frédéric KridelkaDépartement de Gynécologie-Obstétrique, Hôpital Universitaire de Liège, Université de Liège (ULiège), Avenue de L'Hôpital 1, 4000 Liège, Belgique.
Florence HanocqDépartement de Gynécologie-Obstétrique, Hôpital Universitaire de Liège, Université de Liège (ULiège), Avenue de L'Hôpital 1, 4000 Liège, Belgique.
Frédéric GoffinDépartement de Gynécologie-Obstétrique, Hôpital Universitaire de Liège, Université de Liège (ULiège), Avenue de L'Hôpital 1, 4000 Liège, Belgique.
Patricia NervoDépartement de Gynécologie-Obstétrique, Hôpital Universitaire de Liège, Université de Liège (ULiège), Avenue de L'Hôpital 1, 4000 Liège, Belgique.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Complete hydatidiform moles are precancerous gestational trophoblastic diseases, with 15%-20% progressing to post-molar neoplasia. The gold standard treatment of low-risk neoplasia is single-agent chemotherapy. A second curettage is an alternative to avoid chemotherapy; hysteroscopic resection is not described in the guidelines. We report a case of post-molar neoplasia treated using a mechanical hysteroscopic tissue removal system (TruClear°) and review the limited literature on the subject. A patient was diagnosed with low-risk post-molar neoplasia in our department. Ultrasound evaluation revealed uterine trophoblastic retention, which was managed with mechanical hysteroscopic resection. In conclusion, hysteroscopic resection could be a potential alternative to second curettage in highly selected cases of low-risk post-molar neoplasia.

Indexed as

gestational trophoblastic neoplasiahydatidiform moleshysteroscopic resection

Identifiers

PMID40191667
PMCPMC11972626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.